Navigation Links
Cancer Medicine Advances on Many Fronts
Date:12/23/2008

as much as 21 percent in patients with non-small cell lung cancer which expressed the epidermal growth factor receptor (EGFR). Patients receiving Erbitux in a recent trial lived an average of 11.3 months vs. 10.1 months in those receiving a placebo. Lung cancer is the number-one cancer killer among men and women; only 5 percent of those diagnosed with this type of lung cancer survive five years.
  • The new chemotherapy drug Gemcitabine (Gemzar) doubled disease-free survival from 6.9 months to 13.4 months in pancreatic cancer patients, and increased overall survival from 20.2 months to 22.8 months in patients with early-stage pancreatic cancer who had undergone surgery. Again, only 5 percent of people receiving this diagnosis live five years.
  • In the area of new drug approvals:

    • Bendamustine (Treanda) "eliminated" chronic lymphocytic leukemia (CLL) in one-third of patients compared with 2 percent who went with current standard therapy, and extended survival without a recurrence to 21.7 months from 9.3 months. The drug was approved in March of 2008 and is now indicated as first-line treatment for the disease.
    • Bevacizumab (Avastin), another monoclonal antibody, was approved (in conjunction with the chemotherapy drug paclitaxel (Taxol) for women with previously untreated HER2-negative, metastatic breast cancer. A trial the year before had found the combination doubled disease-free survival compared with women receiving chemo alone. A second trial, this one from 2008, confirmed the findings.

    In the area of reducing cancer recurrence:

    • Women with breast cancer who have already taken tamoxifen for five years and who take additional hormone therapy in the form of an aromatase inhibitor or more tamoxifen may reduce even further the chances of the cancer coming back.
    • Adding the osteoporosis drug zoledronic acid (Zometa) in premenopausal women with early-stage breast ca
      '/>"/>

    Copyright©2008 ScoutNews,LLC.
    All rights reserved  

    Page: 1 2 3 4

    Related medicine news :

    1. 5,000 Medical Leaders Report Latest Advancements in Biomedical Technologies; Breakthroughs by 2015 Predicted for Alzheimer's, Heart Disease, Cancer, and Diabetes
    2. E. coli engineered to produce important class of antibiotic, anti-cancer drugs
    3. Gene Variant Tied to Smokers Risk of Lung Cancer
    4. Renowned Cancer Researcher Dan Von Hoff, M.D. Advocates for 'The Lost Opportunity in Phase I Oncology Trials'
    5. Holiday Online Auction - Dedicated to Awareness of Male Breast Cancer - Hosted by John W. Nick Foundation, Inc. at MaleBreastCancer.org
    6. Mutations common to cancer and developmental disorder examined in a novel disease model
    7. SNPs of ABC transporter genes linked to lung cancer risk
    8. Gene Boosts Drinkers Colon Cancer Risk
    9. Groundbreaking, inexpensive, pocket-sized ultrasound device can help treat cancer, relieve arthritis
    10. New study shows that a cough medicine ingredient could effectively treat prostate cancer
    11. Marital Distress May Affect Breast Cancer Recovery
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    Related Image:
    Cancer Medicine Advances on Many Fronts
    (Date:9/2/2014)... become an increasing concern to health officials both in ... Department of Health and Mental Hygiene, the number of ... the number of such deaths in 2000. Much of ... in nonmedical prescription opioid (PO) use among teens and ... youth who transitioned from POs to heroin. , ...
    (Date:9/2/2014)... Two Kansas State University biochemists have discovered a family ... Staphylococcus aureus , a pathogenic bacterium that can ... , Brian Geisbrecht, professor of biochemistry and molecular biophysics, ... S. aureus , which is the cause of increasing ... journal Proceedings of the National Academy of Sciences ...
    (Date:9/2/2014)... that a mother,s eating habits prior to pregnancy, during ... her offspring and their propensity for developing weight problems, ... this phenomenon were unclear. According to new research published ... FASEB Journal F , scientists using an animal model ... an offspring,s risk of future obesity. This link hinges ...
    (Date:9/2/2014)... Many people believe that marijuana is not addictive, but ... people are able to obtain and consume cannabis legally ... are less likely to perceive it as addictive or ... General Hospital,s Center for Addiction Medicine, said in a ... use can have significant consequences, and we know that ...
    (Date:9/2/2014)... HMP Communications Holdings , LLC, a leader ... the acquisition of Nutrition411.com , a vibrant news ... who integrate diet and nutrition into patient consultations. , ... , Late-breaking news related to nutrition and disease ... oncology, renal disease, wound care, and pediatrics , ...
    Breaking Medicine News(10 mins):Health News:NYC teens and young adults who abuse prescription at high risk for overdose 2Health News:NYC teens and young adults who abuse prescription at high risk for overdose 3Health News:Biochemists find new treatment options for staph infections, inflammatory diseases 2Health News:How genes link a mother's diet to the risk of obesity in her offspring 2Health News:'Pot Addiction' May Be Real, Study Suggests 2Health News:HMP Communications Holdings, LLC, Acquires Nutrition411.com 2
    ... converts to Masimo SET pulse oximetry and leverages ... ... capabilities, IRVINE, Calif., Feb. 13 Masimo, the inventor,of Pulse ... of UCSF Medical Center,s,system-wide implementation of Masimo SET pulse oximetry and ...
    ... SEATTLE, Feb. 13 An intriguing new offering ... Climb to Fight,Breast Cancer(R) benefiting Fred Hutchinson Cancer Research ... international slate of peaks to,include two expeditions to central ... (17,343 feet). Both trips will be led by,professional guides ...
    ... Underwriters, Inc. (Darwin) (NYSE: DR ) ... Specialty Product Network Insurance,Services, Inc. (ASPN)., ... the announced arrangement, ASPN,s nationwide team of ... intended to spread the,word about Darwin,s unique ...
    ... been able to eradicate the virus from infected individuals who ... HIV in hideouts known as viral reservoirs. One important reservoir ... due to the large number of HIV target cells that ... largely contained in lymph nodes and patches of lymphocytes that ...
    ... TOWN, W.V., Feb. 13 ReBuilder Medical,Technologies, ... of the art,electronic devices for diabetic peripheral ... up 89% over last year, details,are available ... ., (Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO ), ...
    ... results need to be replicated in larger study, experts ... drug originally designed to combat cancer that is now ... arthritis and lupus might also work against a common ... in the Feb. 14 issue of the New ...
    Cached Medicine News:Health News:The University of California at San Francisco Medical Center Pioneers System-wide Adoption of Masimo Rainbow SET Technology 2Health News:The University of California at San Francisco Medical Center Pioneers System-wide Adoption of Masimo Rainbow SET Technology 3Health News:The University of California at San Francisco Medical Center Pioneers System-wide Adoption of Masimo Rainbow SET Technology 4Health News:The University of California at San Francisco Medical Center Pioneers System-wide Adoption of Masimo Rainbow SET Technology 5Health News:Climb to Fight Breast Cancer Offers Peaks for Every Skill Level 2Health News:Darwin Enters into Marketing Partnership with Agency Specialty Product Network 2Health News:HIV persists in the gut despite long-term HIV therapy 2Health News:ReBuilder Medical Technologies, Inc. Announces 2007 Sales Nearly Doubled Sales in 2006 2Health News:Cancer Drug Works Against MS in Early Trial 2Health News:Cancer Drug Works Against MS in Early Trial 3
    (Date:9/2/2014)... , Sept. 2, 2014 Reportlinker.com ... available in its catalogue: Acute Heart ... http://www.reportlinker.com/p0689743/Acute-Heart-Failure-Global-Clinical-Trials-Review-H2-2014.html Acute ... Summary GlobalData,s clinical trial report, ... 2014" provides data on the Acute Heart Failure ...
    (Date:9/2/2014)... SANTA CLARA, Calif. , Sept. 2, 2014 /PRNewswire/ ... , is now offering a special promotion for Invisalign. ... instead of brackets and wires. It is often the ... who prefer the convenience and aesthetics of it. For ... $3,900, which is a significant savings from the usual ...
    (Date:9/2/2014)... September 2, 2014 ... ESC-Kongress 2014 präsentierte GARFIELD-AF-Register bietet einen ... von schlaganfallgefährdeten Patienten in der klinischen ... Daten der nahezu 12.500 ... und unabhängigen Forschungsinitiative zur Untersuchung von ...
    Breaking Medicine Technology:Acute Heart Failure Global Clinical Trials Review, H2, 2014 2Acute Heart Failure Global Clinical Trials Review, H2, 2014 3Acute Heart Failure Global Clinical Trials Review, H2, 2014 4Acute Heart Failure Global Clinical Trials Review, H2, 2014 5Acute Heart Failure Global Clinical Trials Review, H2, 2014 6Acute Heart Failure Global Clinical Trials Review, H2, 2014 7Acute Heart Failure Global Clinical Trials Review, H2, 2014 8Santa Clara Cosmetic Dentist, Dr. Alan Frame, is Now Offering a Special on Invisalign 2Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 2Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 3Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 4Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 5Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 6Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 7Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 8Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 9Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 10Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 11
    ... 15, 2011 Pharmaceutical companies are dramatically increasing ... meet the demands of a patient-empowered, data-driven, outcomes-focused ... alone, pharmaceutical company investment in smart phone apps, ... other programs increased 78%, as companies embrace a ...
    ... Unilife Corporation ("Unilife" or "Company") (Nasdaq: ... the three and six months ended December 31, 2010 (Fiscal ... Completed, on-schedule, the construction of a new ... staff now working out of the new facility ...
    Cached Medicine Technology:Pharmaceutical Industry Rapidly Expanding Partnerships With New Entrants in Health Care Space, Ernst & Young Finds 2Pharmaceutical Industry Rapidly Expanding Partnerships With New Entrants in Health Care Space, Ernst & Young Finds 3Pharmaceutical Industry Rapidly Expanding Partnerships With New Entrants in Health Care Space, Ernst & Young Finds 4Pharmaceutical Industry Rapidly Expanding Partnerships With New Entrants in Health Care Space, Ernst & Young Finds 5Unilife Corporation Announces Financial Results For Fiscal Year 2011 Second Quarter 2Unilife Corporation Announces Financial Results For Fiscal Year 2011 Second Quarter 3Unilife Corporation Announces Financial Results For Fiscal Year 2011 Second Quarter 4Unilife Corporation Announces Financial Results For Fiscal Year 2011 Second Quarter 5Unilife Corporation Announces Financial Results For Fiscal Year 2011 Second Quarter 6Unilife Corporation Announces Financial Results For Fiscal Year 2011 Second Quarter 7
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    Medicine Products: